Kelli Mari Howell's most recent trade in Alphatec Holdings Inc was a trade of 6,050 Common Stock done at an average price of $8.0 . Disclosure was reported to the exchange on Aug. 5, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Alphatec Holdings Inc | Kelli Mari Howell | EVP, CLINICAL STRATEGIES | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.03 per share. | 05 Aug 2022 | 6,050 | 540,098 (0%) | 0% | 8.0 | 48,582 | Common Stock |
Alphatec Holdings Inc | Kelli Mari Howell | EVP, Clinical Strategies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.94 per share. | 18 Mar 2022 | 2,940 | 544,114 (0%) | 0% | 10.9 | 32,164 | Common Stock |
Alphatec Holdings Inc | Kelli Mari Howell | EVP, Clinical Strategies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 30,655 | 547,054 (0%) | 0% | 0 | Common Stock | |
Alphatec Holdings Inc | Kelli Mari Howell | EVP, Clinical Strategies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 25,000 | 516,399 (0%) | 0% | 0 | Common Stock | |
Alphatec Holdings Inc | Kelli Mari Howell | EVP, Clinical Strategies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.23 per share. | 05 Aug 2021 | 6,050 | 491,399 (0%) | 0% | 15.2 | 92,142 | Common Stock |
Alphatec Holdings Inc | Kelli Mari Howell | EVP, Clinical Strategies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.81 per share. | 17 May 2021 | 17,525 | 497,449 (0%) | 0% | 14.8 | 259,545 | Common Stock |
Alphatec Holdings Inc | Kelli Mari Howell | EVP, Clinical Strategies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.33 per share. | 29 Apr 2021 | 11,474 | 512,467 (0%) | 0% | 16.3 | 187,370 | Common Stock |
Alphatec Holdings Inc | Kelli Mari Howell | EVP, Clinical Strategies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 20,000 | 523,941 (0%) | 0% | 0 | Common Stock |